These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23966413)

  • 41. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation.
    Thimme R; Appay V; Koschella M; Panther E; Roth E; Hislop AD; Rickinson AB; Rowland-Jones SL; Blum HE; Pircher H
    J Virol; 2005 Sep; 79(18):12112-6. PubMed ID: 16140789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.
    Lutz CT; Karapetyan A; Al-Attar A; Shelton BJ; Holt KJ; Tucker JH; Presnell SR
    J Immunol; 2011 Apr; 186(8):4590-8. PubMed ID: 21402893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use.
    Hotho DM; Kreefft K; Groothuismink ZM; Janssen HL; de Knegt RJ; Boonstra A
    Antiviral Res; 2013 Mar; 97(3):347-55. PubMed ID: 23291200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.
    Meier UC; Owen RE; Taylor E; Worth A; Naoumov N; Willberg C; Tang K; Newton P; Pellegrino P; Williams I; Klenerman P; Borrow P
    J Virol; 2005 Oct; 79(19):12365-74. PubMed ID: 16160163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.
    Fugier E; Marche H; Thélu MA; Macek Jílková Z; Van Campenhout N; Dufeu-Duchesne T; Leroy V; Zarski JP; Sturm N; Marche PN; Jouvin-Marche E
    PLoS One; 2014; 9(4):e95614. PubMed ID: 24759660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56
    Long L; Jia M; Fan X; Liang H; Wang J; Zhu L; Xie Z; Shen T
    Clin Exp Immunol; 2017 Jul; 189(1):92-102. PubMed ID: 28317093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells.
    Beyersdorf NB; Ding X; Karp K; Hanke T
    Eur J Immunol; 2001 Dec; 31(12):3443-52. PubMed ID: 11745363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High IFN-gamma and TNF production by peripheral NK cells of Colombian patients with different clinical presentation of Plasmodium falciparum.
    Agudelo O; Bueno J; Villa A; Maestre A
    Malar J; 2012 Feb; 11():38. PubMed ID: 22316273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
    J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
    Alter G; Jost S; Rihn S; Reyor LL; Nolan BE; Ghebremichael M; Bosch R; Altfeld M; Lauer GM
    J Hepatol; 2011 Aug; 55(2):278-88. PubMed ID: 21168454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    Yang CM; Yoon JC; Park JH; Lee JM
    PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy.
    Lee S; Watson MW; Flexman JP; Cheng W; Hammond T; Price P
    J Med Virol; 2010 Apr; 82(4):568-74. PubMed ID: 20166183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
    Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
    Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
    Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
    J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.